Laureate Pharma, Inc. has entered a preferred partnership agreement with Boehringer Ingelheim, allowing Laureate’s clients to gain access to BI’s manufacturing technology platform for biopharmaceutical products produced by mammalian cell culture. Through this collaboration, Laureate will now offer its clients bioprocessing services that include: creation and development of production cell lines using Boehringer’s BI HEX expression system; full-service process development a...